Key statistics
On Thursday, TriSalus Life Sciences Inc (TLSI:NMQ) closed at 4.43, 33.43% above the 52 week low of 3.32 set on Nov 21, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.22 |
---|---|
High | 4.50 |
Low | 4.19 |
Bid | 1.79 |
Offer | 6.02 |
Previous close | 4.07 |
Average volume | 40.04k |
---|---|
Shares outstanding | 29.31m |
Free float | 16.61m |
P/E (TTM) | -- |
Market cap | 129.85m USD |
EPS (TTM) | -1.68 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
- TriSalus Reports Q3 2024 Financial Results and Provides Business Update
- TriSalus Life Sciences® Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav® Infusion System to U.S. Veterans with Liver Cancer
- TriSalus Life Sciences Launches TriNav® LV Infusion System and TriGuide™ Guiding Catheters, Expanding Portfolio of PEDD™ Devices for Improved Tumor Treatment
- TriSalus Life Sciences to Host Third Quarter 2024 Financial Results Conference Call
- TriSalus Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit
- TriSalus Life Sciences Announces Appointment of Riad Salem, M.D., to its Scientific Advisory Board
- TriSalus Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of Glass Microspheres to Solid Tumors With PEDD™ Method via the TriNav® Infusion System
More ▼